Bank of Montreal’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Bank of Montreal’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-667	Closed	-$4K	–	4639
2022 Q1	$4K	Buy	+667	New	+$4.2K	﹤0.01%	4079
2021 Q2	–	Sell	-1,023	Closed	-$27K	–	5383
2021 Q1	$27K	Sell	1,023 -531	-34%	-$24.1K	﹤0.01%	3954
2020 Q4	$63K	Sell	1,554 -10,472	-87%	-$379K	﹤0.01%	3834
2020 Q3	$487K	Sell	12,026 -149	-1%	-$6.48K	﹤0.01%	2347
2020 Q2	$576K	Buy	12,175 +5,668	+87%	+$382K	﹤0.01%	2198
2020 Q1	$485K	Buy	6,507 +355	+6%	+$28.4K	﹤0.01%	1996
2019 Q4	$569K	Buy	6,152 +6,069	+7,312%	+$512K	﹤0.01%	2596
2019 Q3	$6K	Buy	83 +4	+5%	+$307	﹤0.01%	4540
2019 Q2	$8K	Buy	+79	New	+$6.12K	﹤0.01%	4608
2015 Q4	–	Sell	-75	Closed	-$54K	–	4498
2015 Q3	$54K	Buy	+75	New	+$80.5K	﹤0.01%	2897

Other funds holding EVFM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of Montreal's EVFM Position: Q2 2022 in Review

Bank of Montreal sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2022, closing a stake of 667 shares — an estimated $4K sold.

Bank of Montreal first reported a position in EVFM in Q3 2015 and held it in 10 quarters. The position peaked at $576K in Q2 2020. 44 funds tracked by Wall St. Rank hold EVFM as of Q2 2022.

Bank of Montreal reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Bank of Montreal sold 667 Evofem Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $4K.
Bank of Montreal first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2015 and held it in 10 quarters.
Bank of Montreal's Evofem Biosciences, Inc. Common Stock position peaked at $576K in Q2 2020.
44 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.